Nina Kimmeskamp‐Kirschbaum

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan et al. · JAMA · 2015 · 673 citations · Full text

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

Gerasimos Filippatos, Stefan D. Anker, Michael Böhm et al. · European Heart Journal · 2016 · 407 citations · Full text

Rationale and Design of Mineralocorticoid Receptor Antagonist Tolerability Study-Heart Failure (ARTS-HF): A Randomized Study of Finerenone vs. Eplerenone in Patients who have Worsening Chronic Heart Failure with Diabetes and/or Chronic Kidney Disease

Bertram Pitt, Stefan D. Anker, Michael Böhm et al. · European Journal of Heart Failure · 2015 · 90 citations · Full text

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94–8862) in Individuals With Renal Impairment

Roland Heinig, Nina Kimmeskamp‐Kirschbaum, Atef Halabi et al. · Clinical Pharmacology in Drug Development · 2016 · 66 citations

Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone – results from first‐in‐man and relative bioavailability studies

Silvia Lentini, Roland Heinig, Nina Kimmeskamp‐Kirschbaum et al. · Fundamental and Clinical Pharmacology · 2015 · 59 citations